ReP USP - Resultado da busca

Artigo de periodico
Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease (2024)
Espinoza-Chávez, Rocío Marisol; Rezende Junior, Celso de Oliveira; Souza, Mariana Laureano de; Chelucci, Rafael Consolin; Duarte, Simone Michelan; Krogh, Renata; Ferreira, Leonardo Luiz Gomes; Valli, Marilia; Oliveira, Aldo Sena de; Andricopulo, Adriano Defini; Dias, Luiz Carlos
Source: ChemMedChem. Unidade: IFSC
Subjects: TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS, DOENÇAS PARASITÁRIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPINOZA-CHÁVEZ, Rocío Marisol et al. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, v. 19, n. 20, p. e202400293, 2024Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202400293. Acesso em: 15 nov. 2024.
APA
Espinoza-Chávez, R. M., Rezende Junior, C. de O., Souza, M. L. de, Chelucci, R. C., Duarte, S. M., Krogh, R., et al. (2024). Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, 19( 20), e202400293. doi:10.1002/cmdc.202400293
NLM
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/cmdc.202400293
Vancouver
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/cmdc.202400293
Artigo de periodico
The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs (2024)
Dobrachinski, Leandro; Ferreira, Leonardo Luiz Gomes; Cirino, Maria Eduarda de; Siqueira, Allan Igor Andrade de; Mafud, Ana Carolina; Mascarenhas, Yvonne Primerano; Andricopulo, Adriano Defini; Moraes, Josué de
Source: Future Medicinal Chemistry. Unidade: IFSC
Subjects: FÁRMACOS, PLANEJAMENTO DE FÁRMACOS, DOENÇAS PARASITÁRIAS, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOBRACHINSKI, Leandro et al. The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs. Future Medicinal Chemistry, v. 16, n. 17, p. 1791-1799, 2024Tradução . . Disponível em: https://doi.org/10.1080/17568919.2024.2379231. Acesso em: 15 nov. 2024.
APA
Dobrachinski, L., Ferreira, L. L. G., Cirino, M. E. de, Siqueira, A. I. A. de, Mafud, A. C., Mascarenhas, Y. P., et al. (2024). The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs. Future Medicinal Chemistry, 16( 17), 1791-1799. doi:10.1080/17568919.2024.2379231
NLM
Dobrachinski L, Ferreira LLG, Cirino ME de, Siqueira AIA de, Mafud AC, Mascarenhas YP, Andricopulo AD, Moraes J de. The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs [Internet]. Future Medicinal Chemistry. 2024 ; 16( 17): 1791-1799.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1080/17568919.2024.2379231
Vancouver
Dobrachinski L, Ferreira LLG, Cirino ME de, Siqueira AIA de, Mafud AC, Mascarenhas YP, Andricopulo AD, Moraes J de. The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs [Internet]. Future Medicinal Chemistry. 2024 ; 16( 17): 1791-1799.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1080/17568919.2024.2379231
Artigo de periodico
Development of a novel chemoinformatic tool for natural product databases (2023)
Carmo, Paulo Ricardo Viviurka do ; Marcacini, Ricardo Marcondes ; Valli, Marilia ; Silva-Silva, João Victor ; Ferreira, Leonardo Luiz Gomes ; Pilon, Alan Cesar ; Bolzani, Vanderlan da Silva ; Andricopulo, Adriano Defini ; Marx, Edgard
Source: Future Drug Discovery. Unidades: ICMC, IFSC
Subjects: DESCOBERTA DE CONHECIMENTO, APRENDIZADO COMPUTACIONAL, BANCO DE DADOS, FÁRMACOS, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARMO, Paulo Ricardo Viviurka do et al. Development of a novel chemoinformatic tool for natural product databases. Future Drug Discovery, v. 5, n. 2, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.4155/fdd-2023-0007. Acesso em: 15 nov. 2024.
APA
Carmo, P. R. V. do, Marcacini, R. M., Valli, M., Silva-Silva, J. V., Ferreira, L. L. G., Pilon, A. C., et al. (2023). Development of a novel chemoinformatic tool for natural product databases. Future Drug Discovery, 5( 2), 1-11. doi:10.4155/fdd-2023-0007
NLM
Carmo PRV do, Marcacini RM, Valli M, Silva-Silva JV, Ferreira LLG, Pilon AC, Bolzani V da S, Andricopulo AD, Marx E. Development of a novel chemoinformatic tool for natural product databases [Internet]. Future Drug Discovery. 2023 ; 5( 2): 1-11.[citado 2024 nov. 15 ] Available from: https://doi.org/10.4155/fdd-2023-0007
Vancouver
Carmo PRV do, Marcacini RM, Valli M, Silva-Silva JV, Ferreira LLG, Pilon AC, Bolzani V da S, Andricopulo AD, Marx E. Development of a novel chemoinformatic tool for natural product databases [Internet]. Future Drug Discovery. 2023 ; 5( 2): 1-11.[citado 2024 nov. 15 ] Available from: https://doi.org/10.4155/fdd-2023-0007
Artigo de periodico
DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
Souza, Márcia Maria de; Cenci, Arthur Ribeiro; Teixeira, Kerolain Faoro; Machado, Valkiria; Mendes, Majory Christina Garcia; Gonçalves, Ana Elisa; Dalmagro, Ana Paula; Cazarin, Camila André; Ferreira, Leonardo Luiz Gomes ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 15 nov. 2024.
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Artigo de periodico
Molecular modeling, virtual screening, and molecular dynamics for Leishmania infantum methionyl-tRNA synthetase (2022)
Teles, Henrique Rodrigues; Valli, Marilia ; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Journal of Physical Chemistry B. Unidade: IFSC
Subjects: LEISHMANIA, LEISHMANIA INFANTUM, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Henrique Rodrigues et al. Molecular modeling, virtual screening, and molecular dynamics for Leishmania infantum methionyl-tRNA synthetase. Journal of Physical Chemistry B, v. 126, n. 51, p. 10834-10843, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.jpcb.2c05427. Acesso em: 15 nov. 2024.
APA
Teles, H. R., Valli, M., Ferreira, L. L. G., & Andricopulo, A. D. (2022). Molecular modeling, virtual screening, and molecular dynamics for Leishmania infantum methionyl-tRNA synthetase. Journal of Physical Chemistry B, 126( 51), 10834-10843. doi:10.1021/acs.jpcb.2c05427
NLM
Teles HR, Valli M, Ferreira LLG, Andricopulo AD. Molecular modeling, virtual screening, and molecular dynamics for Leishmania infantum methionyl-tRNA synthetase [Internet]. Journal of Physical Chemistry B. 2022 ; 126( 51): 10834-10843.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1021/acs.jpcb.2c05427
Vancouver
Teles HR, Valli M, Ferreira LLG, Andricopulo AD. Molecular modeling, virtual screening, and molecular dynamics for Leishmania infantum methionyl-tRNA synthetase [Internet]. Journal of Physical Chemistry B. 2022 ; 126( 51): 10834-10843.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1021/acs.jpcb.2c05427
Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 15 nov. 2024.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico
Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs (2022)
Roquini, Daniel B.; Silva, Gabriel L.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Wilairatana, Polrat; Moraes, Josué de
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: HELMINTÍASE, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUINI, Daniel B. et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, v. 13, p. 901459-1-901459-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.901459. Acesso em: 15 nov. 2024.
APA
Roquini, D. B., Silva, G. L., Ferreira, L. L. G., Andricopulo, A. D., Wilairatana, P., & Moraes, J. de. (2022). Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, 13, 901459-1-901459-9. doi:10.3389/fphar.2022.901459
NLM
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Vancouver
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Artigo de periodico
Hierarchical clustering and target-independent QSAR for antileishmanial oxazole and oxadiazole derivatives (2022)
Teles, Henrique Rodrigues; Ferreira, Leonardo Luiz Gomes ; Valli, Marilia ; Coelho, Fernando; Andricopulo, Adriano Defini
Source: International Journal of Molecular Sciences. Unidade: IFSC
Subjects: ANTIPARASITÁRIOS, LEISHMANIA INFANTUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Henrique Rodrigues et al. Hierarchical clustering and target-independent QSAR for antileishmanial oxazole and oxadiazole derivatives. International Journal of Molecular Sciences, v. 23, n. 16, p. 8898-1-8898-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23168898. Acesso em: 15 nov. 2024.
APA
Teles, H. R., Ferreira, L. L. G., Valli, M., Coelho, F., & Andricopulo, A. D. (2022). Hierarchical clustering and target-independent QSAR for antileishmanial oxazole and oxadiazole derivatives. International Journal of Molecular Sciences, 23( 16), 8898-1-8898-16. doi:10.3390/ijms23168898
NLM
Teles HR, Ferreira LLG, Valli M, Coelho F, Andricopulo AD. Hierarchical clustering and target-independent QSAR for antileishmanial oxazole and oxadiazole derivatives [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 16): 8898-1-8898-16.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/ijms23168898
Vancouver
Teles HR, Ferreira LLG, Valli M, Coelho F, Andricopulo AD. Hierarchical clustering and target-independent QSAR for antileishmanial oxazole and oxadiazole derivatives [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 16): 8898-1-8898-16.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/ijms23168898
Trabalho de evento-resumo
Ligand-based drug design studies for a series of oxazole and oxadiazole derivatives with antileishmanial activity (2022)
Teles, Henrique Rodrigues; Ferreira, Leonardo Luiz Gomes ; Valli, Marilia ; Andricopulo, Adriano Defini
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidade: IFSC
Subjects: ANTIPARASITÁRIOS, LEISHMANIA INFANTUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Henrique Rodrigues et al. Ligand-based drug design studies for a series of oxazole and oxadiazole derivatives with antileishmanial activity. 2022, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2022. Disponível em: https://www.eventweb.com.br/45rasbq/specific-files/manuscripts/45rasbq/732_1650850269.pdf. Acesso em: 15 nov. 2024.
APA
Teles, H. R., Ferreira, L. L. G., Valli, M., & Andricopulo, A. D. (2022). Ligand-based drug design studies for a series of oxazole and oxadiazole derivatives with antileishmanial activity. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/45rasbq/specific-files/manuscripts/45rasbq/732_1650850269.pdf
NLM
Teles HR, Ferreira LLG, Valli M, Andricopulo AD. Ligand-based drug design studies for a series of oxazole and oxadiazole derivatives with antileishmanial activity [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: https://www.eventweb.com.br/45rasbq/specific-files/manuscripts/45rasbq/732_1650850269.pdf
Vancouver
Teles HR, Ferreira LLG, Valli M, Andricopulo AD. Ligand-based drug design studies for a series of oxazole and oxadiazole derivatives with antileishmanial activity [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: https://www.eventweb.com.br/45rasbq/specific-files/manuscripts/45rasbq/732_1650850269.pdf
Trabalho de evento-resumo
Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies (2022)
Sparenberg, Daniela D.; Machado, Valkiria; Cenci, Arthur Ribeiro ; Teixeira, Kerolain Faoro; Sens, Larissa; Tizziani, Tiago ; Nunes, Ricardo José; Ferreira, Leonardo Luiz Gomes ; Yunes, Rosendo Augusto; Sandjo, Louis Pergaud; Andricopulo, Adriano Defini ; Oliveira, Aldo Sena de
Source: Anais. Conference titles: Reunião da Sociedade Brasileira de Química - Regional Sul - SBQ-Sul. Unidade: IFSC
Subjects: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPARENBERG, Daniela D. et al. Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. 2022, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2022. Disponível em: https://www.sbqsul2022.com.br/anais/trabalhos/anais01?simposio=277#D. Acesso em: 15 nov. 2024.
APA
Sparenberg, D. D., Machado, V., Cenci, A. R., Teixeira, K. F., Sens, L., Tizziani, T., et al. (2022). Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.sbqsul2022.com.br/anais/trabalhos/anais01?simposio=277#D
NLM
Sparenberg DD, Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS de. Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: https://www.sbqsul2022.com.br/anais/trabalhos/anais01?simposio=277#D
Vancouver
Sparenberg DD, Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS de. Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: https://www.sbqsul2022.com.br/anais/trabalhos/anais01?simposio=277#D
Trabalho de evento-resumo
Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity (2022)
Oliveira, Aldo Sena de ; Salcedo, David Leandro Palomino; Zapp, Eduardo; Brondani, Daniela; Hoppe, Thaynara D.; Brondani, Patrícia B.; Meier, Lidiane; Johann, Susana; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidade: IFSC
Subjects: ANTIFÚNGICOS, ANTIOXIDANTES, CANDIDA ALBICANS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Aldo Sena de et al. Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity. 2022, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2022. Disponível em: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf. Acesso em: 15 nov. 2024.
APA
Oliveira, A. S. de, Salcedo, D. L. P., Zapp, E., Brondani, D., Hoppe, T. D., Brondani, P. B., et al. (2022). Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
NLM
Oliveira AS de, Salcedo DLP, Zapp E, Brondani D, Hoppe TD, Brondani PB, Meier L, Johann S, Ferreira LLG, Andricopulo AD. Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Vancouver
Oliveira AS de, Salcedo DLP, Zapp E, Brondani D, Hoppe TD, Brondani PB, Meier L, Johann S, Ferreira LLG, Andricopulo AD. Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity [Internet]. Anais. 2022 ;[citado 2024 nov. 15 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Artigo de periodico
Chemoinformatics studies on a series of imidazoles as cruzain inhibitors (2021)
Medeiros, Alex Rogério; Ferreira, Leonardo Luiz Gomes ; Souza, Mariana Laureano de ; Rezende Junior, Celso de Oliveira ; Espinoza-Chávez, Rocío Marisol ; Dias, Luiz Carlos; Andricopulo, Adriano Defini
Source: Biomolecules. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA, CRISTALOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Alex Rogério et al. Chemoinformatics studies on a series of imidazoles as cruzain inhibitors. Biomolecules, v. 11, n. 4, p. 579-1-579-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11040579. Acesso em: 15 nov. 2024.
APA
Medeiros, A. R., Ferreira, L. L. G., Souza, M. L. de, Rezende Junior, C. de O., Espinoza-Chávez, R. M., Dias, L. C., & Andricopulo, A. D. (2021). Chemoinformatics studies on a series of imidazoles as cruzain inhibitors. Biomolecules, 11( 4), 579-1-579-19. doi:10.3390/biom11040579
NLM
Medeiros AR, Ferreira LLG, Souza ML de, Rezende Junior C de O, Espinoza-Chávez RM, Dias LC, Andricopulo AD. Chemoinformatics studies on a series of imidazoles as cruzain inhibitors [Internet]. Biomolecules. 2021 ; 11( 4): 579-1-579-19.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/biom11040579
Vancouver
Medeiros AR, Ferreira LLG, Souza ML de, Rezende Junior C de O, Espinoza-Chávez RM, Dias LC, Andricopulo AD. Chemoinformatics studies on a series of imidazoles as cruzain inhibitors [Internet]. Biomolecules. 2021 ; 11( 4): 579-1-579-19.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/biom11040579
Parte de monografia/livro
Structure-based drug design (2021)
Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Burger's medicinal chemistry, drug discovery and development. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, MACROMOLÉCULA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Structure-based drug design. Burger's medicinal chemistry, drug discovery and development. Tradução . Hoboken: Wiley, 2021. p. 6032 . Disponível em: https://doi.org/10.1002/0471266949.bmc141.pub2. Acesso em: 15 nov. 2024.
APA
Ferreira, L. L. G., & Andricopulo, A. D. (2021). Structure-based drug design. In Burger's medicinal chemistry, drug discovery and development (p. 6032 ). Hoboken: Wiley. doi:10.1002/0471266949.bmc141.pub2
NLM
Ferreira LLG, Andricopulo AD. Structure-based drug design [Internet]. In: Burger's medicinal chemistry, drug discovery and development. Hoboken: Wiley; 2021. p. 6032 .[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/0471266949.bmc141.pub2
Vancouver
Ferreira LLG, Andricopulo AD. Structure-based drug design [Internet]. In: Burger's medicinal chemistry, drug discovery and development. Hoboken: Wiley; 2021. p. 6032 .[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/0471266949.bmc141.pub2
Artigo de periodico
Antioxidant activity, molecular docking, quantum studies and in vivo antinociceptive activity of sulfonamides derived from carvacrol (2021)
Oliveira, Aldo Sena de ; Llanes, Luana C.; Nunes, Ricardo J.; Nucci-Martins, Catharina; Souza, Anacleto Silva de ; Palomino-Salcedo, David Leandro; Dávila-Rodríguez, María-José ; Ferreira, Leonardo Luiz Gomes ; Santos, Adair R. S.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: ANTIOXIDANTES (ATIVIDADE), ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Aldo Sena de et al. Antioxidant activity, molecular docking, quantum studies and in vivo antinociceptive activity of sulfonamides derived from carvacrol. Frontiers in Pharmacology, v. No 2021, p. 788850-1-788850-16 + supplementary material, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.788850. Acesso em: 15 nov. 2024.
APA
Oliveira, A. S. de, Llanes, L. C., Nunes, R. J., Nucci-Martins, C., Souza, A. S. de, Palomino-Salcedo, D. L., et al. (2021). Antioxidant activity, molecular docking, quantum studies and in vivo antinociceptive activity of sulfonamides derived from carvacrol. Frontiers in Pharmacology, No 2021, 788850-1-788850-16 + supplementary material. doi:10.3389/fphar.2021.788850
NLM
Oliveira AS de, Llanes LC, Nunes RJ, Nucci-Martins C, Souza AS de, Palomino-Salcedo DL, Dávila-Rodríguez M-J, Ferreira LLG, Santos ARS, Andricopulo AD. Antioxidant activity, molecular docking, quantum studies and in vivo antinociceptive activity of sulfonamides derived from carvacrol [Internet]. Frontiers in Pharmacology. 2021 ; No 2021 788850-1-788850-16 + supplementary material.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2021.788850
Vancouver
Oliveira AS de, Llanes LC, Nunes RJ, Nucci-Martins C, Souza AS de, Palomino-Salcedo DL, Dávila-Rodríguez M-J, Ferreira LLG, Santos ARS, Andricopulo AD. Antioxidant activity, molecular docking, quantum studies and in vivo antinociceptive activity of sulfonamides derived from carvacrol [Internet]. Frontiers in Pharmacology. 2021 ; No 2021 788850-1-788850-16 + supplementary material.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2021.788850

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Non normalized affiliation